Central Precocious Puberty: Treatment with Triptorelin 11.25 mg

Background. Few data are available on quarterly 11.25 mg GnRH analog treatment in central precocious puberty (CPP). Aim. To assess the efficacy of triptorelin 11.25 mg in children with CPP. Patients. 17 patients (16 females) with CPP (7.9 ± 0.9 years) were treated with triptorelin 11.25 mg/90 days....

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Chiocca, Elena, Dati, Eleonora, Baroncelli, Giampiero I., Cassio, Alessandra, Wasniewska, Malgorzata, Galluzzi, Fiorella, Einaudi, Silvia, Cappa, Marco, Russo, Gianni, Bertelloni, Silvano
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: The Scientific World Journal 2012
Pynciau:
Clinical Study
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC3356708/
https://ncbi.nlm.nih.gov/pubmed/22645436
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1100/2012/583751
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg